| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Employee stock purchase plan proceeds | 5 | 5 |
| Cash in lieu of fractional shares for reverse stock split | 1 | 1 |
| Net cash used in financing activities | -534 | -382 |
| Net increase in cash and cash equivalents | 568 | 2,563 |
| Cash and cash equivalents at beginning of period | 9,994 | - |
| Cash and cash equivalents at end of period | 10,562 | - |
Sensei Biotherapeutics, Inc. (SNSE)
Sensei Biotherapeutics, Inc. (SNSE)